BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 7, 2024, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2024 FINANCIAL RESULTS
Bio-Techne (NASDAQ: TECH) has announced a conference call and webcast scheduled for August 7, 2024, at 8:00 a.m. CDT to review their fourth quarter and fiscal 2024 financial results.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Bio-Techne (NASDAQ: TECH) has announced a conference call and webcast scheduled for August 7, 2024, at 8:00 a.m. CDT to review their fourth quarter and fiscal 2024 financial results. Investors and interested parties can access the call via phone or webcast. For those unable to attend live, a recorded rebroadcast will be available from 11:00 a.m. CDT on August 7 until 11:00 p.m. CDT on September 7, 2024. This event provides an opportunity for stakeholders to gain insights into Bio-Techne's financial performance and future outlook.
Details
News Market Reaction – TECH
The recorded move for TECH in the trading session of this news was -0.13%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Access to the discussion may be obtained as follows:
Time: | 8:00 a.m. CDT |
Date: | August 7, 2024 |
Dial-in: | 1-800-343-4136 or 1-203-518-9843 (for international callers) |
Conference ID: | BioTechne |
Webcast: | |
A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 11156560.
The replay will be available from 11:00 a.m. CDT on Wednesday, August 7, 2024, until 11:00 p.m. CDT on Saturday, September 7, 2024.
About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated over
Contact: David Clair, Vice President, Investor Relations & Corporate Development
david.clair@bio-techne.com
612-656-4416
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-host-conference-call-on-august-7-2024-to-announce-fourth-quarter-and-fiscal-2024-financial-results-302196342.html
SOURCE Bio-Techne Corporation
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.